Your browser doesn't support javascript.
loading
A CHO stable pool production platform for rapid clinical development of trimeric SARS-CoV-2 spike subunit vaccine antigens.
Joubert, Simon; Stuible, Matthew; Lord-Dufour, Simon; Lamoureux, Linda; Vaillancourt, François; Perret, Sylvie; Ouimet, Manon; Pelletier, Alex; Bisson, Louis; Mahimkar, Rohan; Pham, Phuong Lan; L Ecuyer-Coelho, Helene; Roy, Marjolaine; Voyer, Robert; Baardsnes, Jason; Sauvageau, Janelle; St-Michael, Frank; Robotham, Anna; Kelly, John; Acel, Andrea; Schrag, Joseph D; El Bakkouri, Majida; Durocher, Yves.
Afiliação
  • Joubert S; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada.
  • Stuible M; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada.
  • Lord-Dufour S; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada.
  • Lamoureux L; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada.
  • Vaillancourt F; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada.
  • Perret S; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada.
  • Ouimet M; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada.
  • Pelletier A; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada.
  • Bisson L; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada.
  • Mahimkar R; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada.
  • Pham PL; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada.
  • L Ecuyer-Coelho H; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada.
  • Roy M; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada.
  • Voyer R; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada.
  • Baardsnes J; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada.
  • Sauvageau J; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, Ontario, Canada.
  • St-Michael F; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, Ontario, Canada.
  • Robotham A; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, Ontario, Canada.
  • Kelly J; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, Ontario, Canada.
  • Acel A; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada.
  • Schrag JD; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada.
  • El Bakkouri M; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada.
  • Durocher Y; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Québec, Canada.
Biotechnol Bioeng ; 120(7): 1746-1761, 2023 07.
Article em En | MEDLINE | ID: mdl-36987713

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Clinical_trials / Guideline Limite: Animals / Humans Idioma: En Revista: Biotechnol Bioeng Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Clinical_trials / Guideline Limite: Animals / Humans Idioma: En Revista: Biotechnol Bioeng Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá